Synovial sarcoma cells transduced with the SYT-SSX2 carcinogenic genotype often reveal a unique cytoskeletal phenotype due to the direct activation of the EPH/ephrin signaling pathway [25]. The gene discussed is EPHA1; the disease is synovial sarcoma.